Cisplatin Nephrotoxicity Is Critically Mediated by the Availability of BECLIN1

Tillmann Bork,Camila Hernando-Erhard,Wei Liang,Zhejia Tian,Kosuke Yamahara,Tobias B. Huber

DOI: https://doi.org/10.3390/ijms25052560

IF: 5.6

2024-02-23

International Journal of Molecular Sciences

Abstract:Cisplatin nephrotoxicity is a critical limitation of solid cancer treatment. Until now, the complex interplay of various pathophysiological mechanisms leading to proximal tubular cell apoptosis after cisplatin exposure has not been fully understood. In our study, we assessed the role of the autophagy-related protein BECLIN1 (ATG6) in cisplatin-induced acute renal injury (AKI)—a candidate protein involved in autophagy and with putative impact on apoptosis by harboring a B-cell lymphoma 2 (BCL2) interaction site of unknown significance. By using mice with heterozygous deletion of Becn1, we demonstrate that reduced intracellular content of BECLIN1 does not impact renal function or autophagy within 12 months. However, these mice were significantly sensitized towards cisplatin-induced AKI, and by using Becn1+/−;Sglt2-Cre;Tomato/EGFP mice with subsequent primary cell analysis, we confirmed that nephrotoxicity depends on proximal tubular BECLIN1 content. Mechanistically, BECLIN1 did not impact autophagy or primarily the apoptotic pathway. In fact, a lack of BECLIN1 sensitized mice towards cisplatin-induced ER stress. Accordingly, the ER stress inhibitor tauroursodeoxycholic acid (TUDCA) blunted cisplatin-induced cell death in Becn1 heterozygosity. In conclusion, our data first highlight a novel role of BECLIN1 in protecting against cellular ER stress independent from autophagy. These novel findings open new therapeutic avenues to intervene in this important intracellular stress response pathway with a promising impact on future AKI management.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve

This paper aims to explore whether the nephrotoxicity induced by Cisplatin is related to the availability of the autophagy-related protein BECLIN1. Specifically, the researchers hope to experimentally verify the role of BECLIN1 in Cisplatin-induced acute kidney injury (AKI) and its effects on apoptosis and endoplasmic reticulum stress.

### Background Information

Cisplatin is a commonly used anticancer drug widely used to treat various solid tumors, such as testicular cancer, esophageal cancer, pancreatic cancer, gastric cancer, and lung cancer. However, Cisplatin's nephrotoxicity is a significant clinical issue, affecting about 28% to 36% of patients. Cisplatin primarily accumulates through excessive uptake by proximal tubular cells, leading to apoptosis and dysfunction. Although autophagy and endoplasmic reticulum stress are known to play important roles in Cisplatin nephrotoxicity, the specific role of BECLIN1 remains unclear.

### Research Methods

1. **Animal Model**: The researchers used BECLIN1 gene heterozygous knockout mice (Becn1+/−) to assess Cisplatin-induced kidney injury.
2. **Cell Culture**: Using fluorescent labeling techniques, the researchers generated green fluorescent-labeled proximal tubular cells and conducted in vitro experiments to further verify the role of BECLIN1.
3. **Molecular Biology Techniques**: Techniques such as Western Blot and immunofluorescence staining were used to detect the expression levels of proteins like BECLIN1, LC3, GRP78, and CHOP, evaluating changes in autophagy and endoplasmic reticulum stress.

### Main Findings

1. **Reduction of BECLIN1 Increases Cisplatin Nephrotoxicity**: Becn1+/− mice showed higher mortality and more severe kidney dysfunction after Cisplatin treatment, including significant increases in blood urea nitrogen and serum creatinine levels.
2. **BECLIN1 Does Not Affect Autophagy**: Although BECLIN1 is a key protein in autophagy, the autophagy levels in Becn1+/− mice were not significantly different from those in wild-type mice after Cisplatin treatment.
3. **BECLIN1 Affects Endoplasmic Reticulum Stress**: The expression of endoplasmic reticulum stress markers GRP78 and CHOP significantly increased in Becn1+/− mice after Cisplatin treatment, indicating that BECLIN1 plays an important role in protecting cells from endoplasmic reticulum stress.
4. **Effect of ER Stress Inhibitor TUDCA**: The use of the ER stress inhibitor TUDCA significantly reduced Cisplatin-induced cell death in Becn1+/− mice, further confirming the protective role of BECLIN1 in endoplasmic reticulum stress.

### Conclusion

This study demonstrates that BECLIN1 plays an important role in Cisplatin-induced nephrotoxicity, primarily by protecting cells from endoplasmic reticulum stress rather than by regulating autophagy or directly participating in apoptosis. This finding provides new insights for the future development of therapies targeting endoplasmic reticulum stress, potentially improving the management of side effects in Cisplatin treatment.